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Abstract
Background: Inappropriate medication use (IMU) by elderly people is a public health problem associated with
adverse effects on health. There are a number of methods for identifying IMU, some involving clinical judgment
and others, consensually generated lists of drugs to be avoided. This review aims to describe studies that used
information from insurance company and social security administrative databases to assess IMU among
community-dwelling elderly and to present the risk factors most often associated with IMU.
Methods: The paper search was conducted in Medline and Embase, using descriptors combined with free terms in
the title or abstract. The limits applied were: publication date from January 1990 to June 2010, species (human)
and publication type (excluding editorials, letters and reviews). Excluded were: case studies; studies in hospitals,
nursing homes, or hospital emergency departments; studies of specific drugs or groups of drugs; studies
exclusively of subgroups of ill, frail elderly or rural populations. Additional studies were identified from reference
lists. Data were selected and extracted after independent reading by two of the authors, with disagreements
resolved by a third author. The primary outcome assessed was prevalence of IMU, defined as the proportion of
elderly who received at least one inappropriate medication.
Results: Of the 628 studies, 19 met the inclusion criteria, 78.9% of them conducted in the USA. All papers included
used explicit criteria of inappropriateness, most commonly Beers criteria (73.7%) in their three versions (1991, 1997
and 2002). Other methods used included Zhan, which is derived from on Beers criteria and was applied in 21% of
the papers selected. The study found that prevalence of IMU ranged from 11.5% to 62.5%. Only 68.4% of the
studies included examined inappropriate use-related factors, the most important being female sex, advanced age
and larger number of drugs.
Conclusions: The results show that the prevalence of IMU among community-dwelling elderly is high and
depends partly on the method used to evaluate improper use. Besides the diversity of methods, other factors, such
as patient sex, age and number of drugs used concurrently, appear to have influenced the estimates of IMU.
Background
The elderly are the segment of society most exposed to
medication. Studies in developed countries show that con-
sumption of medication increases with age and that many
elderly use at least three prescribed drugs concurrently
[1,2]. In developing countries, the proportion of elderly
using at least one medication daily ranges from 85 to 90%
[3-6]. However, physiological and physiopathological pecu-
liarities in this age group lead to differences in the phar-
macokinetics and pharmacodynamics of the medications
administered, making the prescription process complex
and often inappropriate [7,8]. Studies show that elderly
patients can present alterations in practically all pharma-
cokinetic processes (absorption, first-pass metabolism,
bioavailability, distribution, protein building, renal and
hepatic clearance). These alterations can lead to lower
effectiveness of some drugs, such as enalapril, which is a
pro-drug, and its bioavailability can be affected by reduc-
tion of the first-step metabolism [7]. On the other hand,
they can also contribute to increasing risk of adverse drug
reactions; for example, drugs with high hepatic-extraction
ratios, such as the nitrates, barbiturates, lidocaine and pro-
pranolol, may have reduced hepatic metabolism in older
adults [9].
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sidered a major public health problem, given its associa-
tion with morbidity and mortality and in view of health
service costs resulting from adverse reactions [10,11].
Various strategies have been developed to identify inap-
propriate prescription patterns. Methods are based on
implicit criteria, involving clinical judgment grounded in
reviews of the medical literature (Medication Appropriate-
ness Index, for example [12]), and explicit criteria, based
on consensually-generated lists of drugs to be avoided.
One of the most used is the Beers method created in 1991
and updated in 1997 and 2002 [13-15].
The review by Jano & Aparasu [10] shows that, on the
Beers criteria, use of inappropriate medication is asso-
ciated with adverse effects on health, especially hospitaliza-
tions, among elderly residing in the community.
Concomitant use of several medications (polypharmacy) is
also related to adverse reactions, morbidity and mortality
[16].
Various methods have been widely used in several coun-
tries to identify inappropriate prescription patterns and
their effects on the health of the elderly, and to foster
improved therapeutic practice [11,13]. Studies show that
providing information of inappropriate medication use to
health authorities can help improve pharmacotherapy
among the elderly by providing input to regulatory action
with a view to reducing inappropriate prescribing [17].
The aims of this review are to identify and describe stu-
dies that used information from insurance company and
social security administrativ ed a t a b a s e st oa s s e s si n a p -
propriate medication use among community-dwelling
elderly (60 years and older) and to present the risk factors
most often associated with inappropriate medication use.
Methods
Search
The paper search was conducted on the Medline elec-
tronic database, using the PubMed interface. The MeSH
descriptors used were “aged” not “frail elderly” com-
bined with “drug therapy”, “drug utilization”, “pharma-
ceutical preparations”, “drug interactions” and with the
free terms “inappropriate drug”, “inappropriate drugs”,
“inappropriate medication”, “inappropriate medications”,
“inappropriate medicines”, “inappropriate prescribing”,
“inappropriate prescription”, “inappropriate prescrip-
tions”, “inadequate medication”, “suboptimal therapy”,
“suboptimal prescribing” in the paper title or abstract.
The search limits were: publication date from January
1990 to June 2010, species (human), and publication
type (excluding editorials, letters and reviews). The
search strategy was also performed in the Embase data-
base (the complete search strategy is presented in Addi-
tional file 1).
Selection
Papers were selected by two authors independently, and
reviewed by a third author, according to the stages
described below.
After reading the titles returned by the search, we
excluded the following: case studies; studies in hospitals,
nursing homes, or hospital emergency departments; stu-
dies of specific drugs or groups of drugs; and studies
exclusively of subgroups of ill, frail elderly or rural popula-
tions. These same criteria were applied to the abstracts of
the publications selected. Also excluded were guidelines
and studies which offer no inappropriateness frequency
estimates, as well as those without abstracts. The articles
were selected with no language restriction.
On reading the abstracts it was possible, from the nature
of the data, to identify two groups: studies of primary data
sources and studies of secondary data sources. By reading
the Methods section of each study they could be classified
by the nature of the data used. This paper examines the
studies of secondary data sources, i.e. insurance company
and social security administrative databases developed pri-
marily for purposes other than evaluating medication use.
That choice was made in view of their representativeness
and of the power to detect differences, because they con-
tain records on large numbers of people.
The same inclusion and exclusion criteria were
applied in order to select studies retrieved by manual
search in the bibliographic references of the selected
articles.
Reading and data extraction
Each paper was examined for: population studied, inap-
propriateness criterion (Beers, Drug Utilization Review;
Zhan; McLeod; Medication Appropriateness Index, and
others), measures of frequency of inappropriate use (pro-
portion of elderly), description of inappropriate medica-
tions (drugs or classes of drugs), and factors associated
with improper use. The exclusion criteria mentioned
above were applied to the full texts.
The data extraction form and the corresponding instruc-
tion manual for completing it were tested initially with five
articles and subsequently subjected to minor adjustments,
such as including new data record fields or changing for-
mat to accommodate information recording better. It
comprised seven sections, which can be summarized as
follows: identification of the article; description of the
study source data base (type; country; scope); study popu-
lation (individuals/visits/prescription); characterization of
the participants (age; sex; schooling; income; co-morbid-
ity); measures of inappropriate use frequency (proportion
of elderly); inappropriateness criteria used (Beers, 1991;
Beers, 1997; Beers, 2002; Drug Utilization Review; Zhan;
McLeod; Medication Appropriateness Index, and others);
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drugs); associated factors (odds ratio; confidence intervals,
p-value). The form is available from the authors.
During reading of the complete texts, data quality was
also evaluated for inclusion in the review. Although the
Strobe Initiative [18] is not a tool for evaluating study
quality, some points from it were considered here for that
purpose, especially as regards the Methods section, as fol-
lows: (1) Setting: describe the setting, locations, and rele-
vant dates, including recruitment, exposure, follow-up,
and data collection periods; (2) Participants: give the elig-
ibility criteria, and the sources and methods of selection of
participants; (3) Data search: give sources of data and
details of methods of assessment (measurement). These
items had to be present in an article in order for it to be
included in the review.
A number of terms designating inappropriate medica-
tion use were encountered: drugs to be avoided in the
elderly, inappropriate drug use, potentially inappropriate
medication, potentially inappropriate prescribing in the
elderly, and potentially inappropriate prescribing. In this
review all these terms were expressed as IMU (inappropri-
ate medication use).
Analysis
Epidata was used for data input and analysis. A description
of the studies is given as regards country and sample char-
acteristics, inappropriateness criteria used in each article,
and prevalence of IMU defined as the proportion of
elderly who received at least one inappropriate medication.
The factors associated with inappropriate use are also
shown. Proportions were extracted to measure frequencies
relating to the variables country, type of measurement of
IMU used, and drugs/therapeutic classes most identified
as inappropriate.
Results
The search strategy returned 628 papers (Medline and
Embase); the exclusions at each stage are shown in Figure 1.
As regards the quality of the articles, we excluded one
article for not defining sampling criteria and another 8
whose criteria of inappropriateness differed widely from
previously validated criteria (such as Beers [13], Zhan [19]
or McLeod [20]), i.e., they used criteria not specific to the
elderly (2), or made extensive adaptations to drugs lists,
resulting in distortion of validated criteria (4), or focused
on overall quality of patient care (2).
After application of the inclusion and exclusion criteria,
19 studies were selected for analysis. In all these the popu-
lation was studied retrospectively.
It was noted that, over the period reviewed (1990 to
2010), the number of papers published on IMU has
increased steadily in more recent years, and more than
doubled in the past five. Table 1 describes the main
characteristics of the papers included in the review. They
were produced in 5 different countries of North America,
Europe, Oceania and Asia, 78.9% (15/19) of them in the
USA.
Thirty seven percent (7/19) of the studies were based on
nationwide administrative databases. They all presented
data on population size, expressed as numbers of indivi-
duals over 65 years old. One study (1/19) included only
elderly over 70 years old, and one study (1/19) included
elderly over 60 years old. Information on sex was included
in 84.2% (16/19) of the studies. Study sample sizes ranged
from 777 to 2 133 864 elderly.
All papers used explicit criteria of inappropriateness
and 73.7% (14/19) used one of the three versions of Beers
criteria (1991, 1997 and 2002). However, 85.7% (12/14)
adapted the criteria to restrict them to inappropriate
drugs regardless of dosage or specific clinical conditions
or even to drugs available in the country of the study
[21,22]. About 16.0% (3/19) used more than one criterion
in order to evaluate combined inappropriate medication
use [23-25]. Other methods used included Zhan and
HEDIS (derived from Beers criteria), which were applied
in 21% (4/19) [26-29] and 5.3% (1/19) [30] of the studies,
respectively.
There was clear variation in estimates of IMU preva-
lence. Among estimates generated by applying several cri-
teria, prevalence of IMU ranged from 11.5% to 62.5%
(Table 1).
As regards the drugs/therapeutic classes most identified
as inappropriate, 36.8% (7/19) of the studies
[22,27-29,31-33] described the inappropriate medication
as individual drugs, two reported them as therapeutic
classes [21,34]; nine presented rankings of classes and indi-
vidual drugs [23-25,30,35-39], and one did not describe
the inappropriate medications [26].
Of the studies that identified the inappropriate medica-
tions as individual drugs [22,27-29,31-33], 85.7% (6/7)
mentioned amitriptyline; 85.7% (6/7), propoxyphene; and
51.1% (4/7) cyclobenzaprine, among the five inappropriate
drugs most used.
Factors associated with IMU were addressed in 68.4%
(13/19) of the studies. About 15.8% (3/19) used univariate
analyses [29,32,38] and 52.6% (10/19) multivariate ana-
lyses. The factors most often associated with IMU include:
female sex, age and number of drugs prescribed or dis-
pensed (Table 2).
Discussion
Our results suggest that prevalence of IMU is high
among community-dwelling elderly, and that this use is
associated with the female sex, advanced age and the
number of drugs prescribed.
Studies clearly varied widely in their estimates of pre-
valence of inappropriate medication use by the elderly.
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prevalence of IMU ranged from 11.5% to 62.5%. This
variability may result from a number of factors, among
them the diversity of inappropriateness criteria.
Most of the studies used classic explicit criteria, such as
Beers. The Beers criteria, developed in 1991 using modified
Delphi method, consists in a list of 30 drugs to be avoided
in nursing home residents regardless of diagnoses, dose
and frequency of medication use. Updates reflected the
appearance of new drugs and knowledge, and broadened
application of the criteria to ambulatory elderly [13-15].
The latest version (Beers, 2002) considers 48 inappropriate
medications or classes of medications regardless of diagno-
sis or conditions, and inappropriate medications or classes
for 20 conditions. In 2001, Zhan et al. [19] classified 1997
Beers Criteria drugs into 3 categories: “always avoid”,
“rarely appropriate”,a n d“some indications”. In 2003, an
expert panel classified the 2003 Beers Criteria drugs into
the same three categories, but only the categories “always
avoid” and “rarely appropriate” were included in the
HEDIS criteria [30]. The McLeod method, which is also
considered explicit, was developed by a Canadian panel of
experts, and consists in 18 inappropriate medications for
all elderly regardless of diagnoses or conditions, 16 inap-
propriate drug-disease interactions, and 4 inappropriate
drug-drug interactions [20]. Some studies in this review
use more than one criterion [23,24] or more than one ver-
sion of the same criterion simultaneously [25].
628  titles retrieved by 
applying the 
search strategy 
213 titles selected
415 titles excluded 
100 abstracts failed to meet inclusion criteria
10 articles without abstracts
103 abstracts  selected
10 articles failed to meet inclusion criteria 
1 excluded for not defining sampling criteria
8 excluded by poor inappropriateness criteria
68 other than administrative database
16 articles selected
19 articles selected
3 articles selected by manual search
Figure 1 Flowchart of systematic article search and selection for inappropriate medication use among elderly.
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Page 4 of 10Table 1 Prevalence* of Inappropriate Medication Use (IMU), characteristics of studies (1990-2010)
Reference/Year Country/Cohort** Population characteristics
Sample(N); Sex (% Males);
Age (years)
Criteria
# Prevalence
Lai et al., 2009 [21] Taiwan/NHIRD N = 2 133 864 elderly
Age: ≥ 65
Beers 2002 (excluded drug-disease interaction, short-acting bzd, medications not
marketed in Taiwan, not reimbursed by NHI and classified as second-degree
controlled substances)
62.5%
Fick et al., 2008 [35] USA/Southeast Managed Care
Organization
N = 16 877 elderly
Males:39% ***
Age: ≥ 65/mean = 73.3(SD = 6.47)
Beers 2002 (do not use, excluded oxybutinin, dose) 40.7%
§
Pugh et al., 2008 [26] USA/VA N = 850 154 elderly
Males: 98%
Age: ≥ 65
Zhan 26.2%
Bierman et al., 2007
[27]
USA/VA N = 965 756 elderly
Males: 98%***
Age: ≥ 65 years
Zhan 23% (men);
26.7%
(women)
Roughead et al., 2007
[23]
Australia/VA N = 192 363 elderly
Males: 52.6%
Age: ≥ 70/mean = 81.7(SD = 4.8)
Beers 2002/McLeod (do not use) 21.2%
§
Barnett et al., 2006
[28]
USA/VA N = 123 633 elderly
Males:97.3%
Age: ≥ 65/mean = 74.7(SD = 5.8)
Zhan 21.3%
§§
Maio et al., 2006 [22] Italy/Emilia Romagna outpatient
prescriptions claims database
N = 849 425 elderly
Males: 41.1%***
Age: ≥ 65/mean = 75.6(SD = 7.5)
Beers 2002 (do not use; excluded medications not marketed in Italy or not
reimbursed by the Italian National Formulary)
18%
Pugh et al., 2006 [30] USA/NPCD/VA/Large Health
Survey of Veterans
N = 1 096 361 elderly
Males: 98%***
Age: ≥ 65
HEDIS 2006 19.6%
Zuckerman et al.,
2006 [34]
USA/MarketScan Medicare
Supplemental and Coordination
of Benefits
N = 487 383 elderly
Males: 55.5%
Age: ≥ 65/mean = 73.8(SD = nr)
Beers 2002 41.9%
Pugh et al., 2005 [24] USA/VA N = 1 265 434 elderly
Males: 98%
Age: ≥ 65/mean = 73.5(SD = 5.6)
Beers 1997 (dose)/Zhan 23%
Rigler et al., 2005 [36] USA/Kansas Medicaid
beneficiaries
N = 1 163 elderly
Males: 30.5%
Age: ≥ 60
Beers 1997 (do not use) 21%
Simon et al., 2005 [29] USA/10 HMOs N = 157 517 elderly
Males: 43.5%
Age: ≥ 65
Zhan 28.8% (95%
CI 28.6-29.1)
§§
Curtis et al., 2004 [37] USA/Advanced PCS N = 765 423 elderly
Males: 41.7%***
Age: ≥ 65/mean = 73.7(SD = 6.5)
Beers 1997 (do not use) 21.2%
Howard et al., 2004
[25]
Canada/OCB/RPDB N = 777 elderly
Males: 37.5%
Age: ≥ 65/mean = 74.1(SD = 6.0)
Beers 1991/Beers 1997 (included bzd with > 30 days supply and > 1 bzd or NSAID
simultaneously)
16.3%
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0Table 1 Prevalence* of Inappropriate Medication Use (IMU), characteristics of studies (1990-2010) (Continued)
Rigler et al., 2004 [39] USA/Kansas Medicaid
beneficiaries
N = 1 163 elderly
Males: 30.5%
Age: ≥ 65
Beers 1997 (do not use) 21%
Fick et al., 2001 [33] USA/Southeastern
HMO
N = 2 336 elderly
Males: 40.2%***
Age: ≥ 65
Beers 1997(do not use) 24.2%
Mott & Meek, 2000
[38]
USA/Database of ambulatory
pharmacies of a Midwestern
state
N = 1 185 elderly
Males:35.7%***
Age: range 65-97/mean = 74.9(SD =
7.06)
Beers 1997 (do not use) 14.3%
Piecoro et al., 2000
[31]
USA/Kentucky Medicaid
Recipients
N = 44 259 elderly
Age: ≥ 65
Beers 1997 (do not use, excluded antihistamines) 24.4%
Futterman et al., 1997
[32]
USA/HMO Medicare plan/PBM N = 10 076 elderly
Age: ≥ 65
Beers 1991 11.53%
(1994); 12.8%
(1993)
* in the preceding year
** Advanced PCS = outpatient prescription claims database of national pharmaceutical benefit manager; HMO = Health Maintenance Organizations; NHI = National Health Insurance program; NHIRD = National
Health Insurance Research Database - year 2004; NPCD = National Patient Care Database; OCB = Ontario Drug Benefit Plan; PBM = Pharmaceuticals benefit manager; RPDB = Registered Persons Database; VA =
Veterans Affairs administrative and pharmacy database.
*** Recovered values; nr = not reported
# data in brackets refer to the subtype or modification of criteria used in the study: “do not use” refers to drugs that should be avoided in any circumstances, “dose” refers to drug doses that should not be exceeded
and “drug-disease interactions” refers to drugs to avoid in patients with specific conditions; bzd = benzodiazepines; HEDIS = Healthcare Effectiveness Data and Information measures.
§ prevalence in the preceding 6 months;
§§ prevalence in the preceding 18 months
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0Most of the studies adapt the explicit criteria to
exclude items that depend on dosage, use frequency,
diagnosis, or the drug’s availability in the country of the
study. These adaptations are explained in part by the use
of administrative databases containing no details about
the drugs or how they are used. Also, extrapolations are
made to countries other than where the criterion origi-
nated, where dosages may not be the same and prescrip-
tion habits may be different from the method’sc o u n t r y
of origin. Also observed were adaptations to include
drugs with a pharmacological profile similar to those
mentioned in the criterion and available in the study
country. These facts indicate the difficulties involved in
extrapolating criteria from the country of origin to
others. These difficulties are reflected even in the choice
of study population, as was observed in this review: most
of the studies analyzed (79%) were conducted in the
USA, the country of origin of the Beers method, which
also predominated in IMU analysis (74% of the studies).
In addition to the difficulties regarding interchangeability
of criteria, the explicit methods are criticized for their
lack of specificity, given that they do not consider the
characteristics or clinical condition of each patient [11].
Accordingly, many authors prefer to include the term
“potentially inappropriate” in their description of
estimates.
In most of the studies that use multivariate analyses,
IMU is associated with the female sex and advanced age
(Table 2). Also in the multivariate analyses, the number
of drugs used or prescribed seems to be the most impor-
tant factor associated with IMU. In Table 2 the crude
prevalence presented in single studies shows that poly-
pharmacy is the covariate most strongly associated with
IMU. This association suggests that the use of several
drugs may also mean exposure to substances where the
risks outweigh the benefits.
As regards the drugs/therapeutic classes most identi-
fied as inappropriate, the analysis of the medications was
complicated by the heterogeneity of drug presentations.
Classifications are not uniform and the rankings most
used sometimes specify the drugs, sometimes the thera-
peutic classes, or even both drugs and therapeutic classes.
Nonetheless, the studies do single out substances and
therapeutic classes used for diseases highly prevalent
among the world population, such as depression and
anxiety [40]. The medications used to treat these diseases
Table 2 Factors associated with inappropriate medication use (IMU) in multivariate analysis*, articles published
between 1990 and 2010
Reference/Year Sex Age No. of medications
Lai et al., 2009 [21] Male (ref. Female)
0.98 (0.98-0.98)
Age (ref. 65-69)
70-74: 0.99 (0.99-0.99)
75-79: 1.00 (0.99-1.00)
≥ 80: 1.02 (1.02-1.02)
No. of medications
4-6: 2.70 (2.69-2.70)
≥ 7: 4.53(4.52-4.54)
Pugh et al.,2008 [26] Female (ref. Male)
1.25 (1.19-1.32)
Age (ref. ≥ 85)
65-74: 1.16 (1.11-1.22)
75-84: 1.08 (1.04-1.12)
Unique drugs (ref. ≥ 10)
1-3: 0.10(0.10-0.11)
4-6: 0.25 (0.24-0.26)
7-9: 0.46 (0.45-0.47)
Bierman et al.,2007 [27] Female (ref. Male)
1.23 (1.18-1.27)
Age (ref. ≥ 85)
65-74: 1.11 (1.07-1.14)
m
75-84: 1.05 (1.02-1.09)
m
No. of medications
1.17 (1.17-1.17)
m
1.18 (1.17-1.19)
w
Maio et al.,2006 [22] Female (ref. Male)
0.92 (0.91-0.93)
Age (ref. 65-74)
75-84: 1.11 (1.09-1.12)
≥ 85: 1.18 (1.16-1.20)
No. of drugs prescribed (ref. 1-3)
4-6: 2.37 (2.31-2.42)
7-9: 3.91 (3.82-4.01)
≥ 10: 7.33 (7.15-7.51)
Pugh et al.,2006 [30] - Age (ref. ≥ 85)
65-69: 1.30 (1.20-1.30)
m
1.30(1.10-1.60)
w
70-84: 1.10 (1.10-1.10)
m
1.00(0.90-1.20)
w
Unique medications (ref. 1-3)
4-6: 2.20(2.10-2.20)
m
2.30(1.90-2.70)
w
7-9: 3.80(3.80-3.90)
m
4.30(3.70-5.10)
w
≥ 10: 8.20(8.00-8.40)
m
9.60(8.20-11.20)
w
Howard et al., 2004 [25] Female (ref. Male)
1.60 (1.00-2.40)
--
Rigler et al, 2004 [39] Female
**
- No. of prescriptions per month
**
* Values are OR adjusted (95% CI). Factors for adjustment: Lai (2009): physician characteristics (sex, age, and specialty), and visit characteristics; Pugh (2008): race,
mental comorbidities, geriatric care; Bierman (2007): race/ethnicity, psychiatric comorbidity, health care utilization, visits in primary care; Maio (2006): geographic
location; income; chronic condition drug group; Pugh (2006): race/ethnicity; psychiatric comorbidity, serious mental illness or other mental health diagnoses,
outpatient visits; Howard (2004): education, self-reported health; number of conditions. Rigler (2004): age, race.
m value in men;
w value in women
** Female sex and number of prescription per month were associated with higher levels of inappropriate medication use, p ≤ 0.01.
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Page 7 of 10in the elderly are present in several explicit methods and
associated with severe adverse events, such as sedation,
falls and cognitive dysfunctions [13,41]. However, it is
important to consider that only the short-acting benzo-
diazepines were strongly associated with fall-related inju-
ries and that nowadays, the tricyclic antidepressants have
been largely replaced by selective serotonin reuptake
inhibitors because of lesser adverse effects [41]. Prescrip-
tion of medication to treat these diseases thus deserves
close attention, given that withdrawal of such medication
is associated with a reduction in adverse effects, and
improvements in physical and cognitive functions in the
elderly [42].
This review was intended to contribute to knowledge
about pharmacotherapy for the elderly by evaluating a
non-institutionalized population. Our search strategy iden-
tified a large body of literature. Nonetheless, we may have
missed relevant articles that were not identified, unpub-
lished or excluded erroneously. Reliable evaluation of the
vast and heterogeneous bibliographical material was
assured by independent duplicate reading, and review by a
third author at all stages of data selection and extraction.
Certain limitations must be considered, however. Firstly,
this review addressed only studies of administrative data
sources, which are retrospective and have gaps in clinical
information and in drug exposure data. On the other
hand, they offer information on large populations. The
number of articles published has been growing over the
past few years. Contributions to the conceptual framework
[43] and statistical approaches [44] have allowed a better
understanding of the large administrative database as a
valid means to examine the quality of medical services.
Here, they were chosen for their representativeness, which
yields more precise estimates and power to detect differ-
ences that otherwise would not offer statistical signifi-
cance. As observed in Table 2 the confidence intervals of
estimates for the association between inappropriate medi-
cation use and sex, age or number of medications are very
small. Studies of administrative data sources may also be
useful as inexpensive screening tools in areas where qual-
ity can be investigated in greater depth. Lastly, this review
did not address the repercussions of inappropriate medica-
tion use on the health of the elderly nor the capacity of the
methods used to predict adverse outcomes, both of which
are important considerations for clinical practice.
As more studies are published, it may be possible to
measure and record all potentially important covariates.
These should be considered in future studies in order to
improve the ability to identify their impact on the esti-
mates and develop control strategies. Variables such as
sex, age and total number of medications used should be
mandatory in future studies. It is also important to give
attention to other sources of information, such as medi-
cal records and surveys, with a view to ascertaining to
what extent different study designs entail discrepant
results. Moreover, in the future, reviews of articles that
analyze primary data from population surveys - with
information on social variables, demographics, health sta-
tus, diseases, lifestyle habits, and physical and mental lim-
itations - can enrich our understanding of the complex
network of factors involved in prescribing drugs for the
elderly.
Conclusions
Inappropriate medication us ei sap u b l i ch e a l t hp r o b l e m
and must be evaluated constantly as the panorama of
pharmacotherapy changes. However, estimates of IMU
can be influenced by diverse factors relating to the detec-
tion method used and the study population.
Identifying vulnerable patient groups and developing
pharmacological alternatives suited to country-specific
conditions are important strategies for orienting clinical
conduct and risk reduction in this age group.
From reading the articles, the authors identified certain
salient problem areas, which could be worked around in
the future. Prominent among them is the applicability of
the list of drugs. There is a need for scientific evidence-
based lists to be drawn up with clearly defined indicators
of inappropriate medication prescription, as well as drug-
drug and drug-disease interactions [45]. This recommen-
dation is even more important in the case of large admin-
istrative data bases. This would then provide an easily
applicable tool with major potential for research and
monitoring, to be used by researchers and health system
managers. Another still unsolved problem relates to the
existence of lists compiled by only a few countries. It is
important to develop lists appropriate to the products on
sale in each country, so as to make it easier to operatio-
nalize studies, and for surveillance systems to monitor. In
addition, the inclusion of lists of medications inappropri-
ate for the elderly on national drug formularies would
reduce their prescription and use in this age group [46].
However, the development of more suitable criteria of
inappropriateness does not itself guarantee reduced pre-
valence of IMU. Efforts to identify factors associated with
IMU may help policy makers identify vulnerable patient
groups and develop programs to modify prescription pat-
terns [47,48]. Studies of large administrative data bases,
such as those analyzed in this study, can make a major
contribution in this respect. However, it is essential to
develop effective approaches. Geriatric medicine services,
pharmacist interventions in patient care, implementation
of appropriate prescription criteria and computerized
decision-making support systems can improve the appro-
priateness of prescribing for the elderly in ambulatory-
care settings [49-52]. The review by Forsetlund et al [53]
shows that, in nursing homes, under certain circum-
stances, interventions using educational outreach, on-site
Guaraldo et al. BMC Geriatrics 2011, 11:79
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Page 8 of 10education alone or as part of an intervention package and
pharmacists medication review may reduce inappropriate
medication drug use.
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